Sozinibercept was an investigational drug intended to be used to treat certain eye conditions such as wet age-related macular degeneration (AMD). It is administered intravitreally in combination with other Anti-VEGF-A including aflibercept, faricimab, ranibizumab, and bevacizumab.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.